IL6 and metabolic syndrome: ROS induce the secretion of pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), from adipose tissue macrophages and adipocytes, causing a persistent inflammatory condition that leads to insulin resistance, dyslipidemia, and overall metabolic dysfunction [37].